Back
Dermata Therapeutics, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
12
DRMA
Dermata Therapeutics, Inc.
Last Price:
$2.14
Seasonality Move:
-34.61%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiDermata Therapeutics, Inc. Stock Forecast
-
Is Dermata Therapeutics, Inc. Stock Undervalued?The current Dermata Therapeutics, Inc. [DRMA] share price is $2.30. The Score for DRMA is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Dermata Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Dermata Therapeutics, Inc. Stock Rating
Data Unavailable
Dermata Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dermatarx.com
52-Week Data
52-Week High:
23.70
52-Week Low:
2.21
Prediction Charts
Market Cap:
2.4M
Price in USD:
2.30
Volume:
66.3K
Beta:
0.54
Technical Analysis
SMA50:
3.30
SMA100:
4.48
SMA200:
6.44
52-Wk Change:
-79.09%
Stock Predictions
-
Is Dermata Therapeutics, Inc. stock public?Yes, Dermata Therapeutics, Inc. is a publicly traded company.
-
What is the Dermata Therapeutics, Inc. stock quote today?The Dermata Therapeutics, Inc. stock price is 2.30 USD today.
-
How to buy Dermata Therapeutics, Inc. stock online?You can buy Dermata Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 3.03 | 3.14 | 3.14 | 3.03 |
| Dec-1 | 3.10 | 2.96 | 3.16 | 2.92 |
| Dec-2 | 3.08 | 2.99 | 3.16 | 2.93 |
| Dec-3 | 2.89 | 3.01 | 3.03 | 2.89 |
| Dec-4 | 2.84 | 2.52 | 2.84 | 2.34 |
| Dec-5 | 2.59 | 2.80 | 2.92 | 2.55 |
| Dec-8 | 2.90 | 2.77 | 2.95 | 2.69 |
| Dec-9 | 2.78 | 2.90 | 2.96 | 2.66 |
| Dec-10 | 2.85 | 2.90 | 2.98 | 2.72 |
| Dec-11 | 2.87 | 2.75 | 2.87 | 2.62 |
| Dec-12 | 2.80 | 2.63 | 2.81 | 2.61 |
| Dec-15 | 2.71 | 2.48 | 2.71 | 2.47 |
| Dec-16 | 2.50 | 2.32 | 2.55 | 2.21 |
| Dec-17 | 2.35 | 2.30 | 2.42 | 2.25 |
Dermata Therapeutics, Inc. Earnings
Data Unavailable
Dermata Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
* Dermata Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.